CyrusBio is a spinout of David Baker’s (2024 Nobel Prize Winner in Chemistry) lab at the University of Washington. Cyrus is an AI-driven discovery platform focused on non-antibody, natural proteins that show potential of being turned into actual therapeutics with the help of AI.
CyrusBio wanted their new site to help potential investors or partners quickly understand that CyrusBio doesn’t look for novel therapies – rather, they are experts in generating tons of different drug candidates quickly and efficiently.
Stellar Biotech Design worked closely with the founders to design a website that positions CyrusBio as the leader in finding and turning natural proteins into actual therapeutics. The new site shows how CyrusBio’s innovative AI-platform helps scientists find better, safer or more potent drug candidates.
